Hay CR - Search Results

1

Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.

Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, Bagnall R, Peake IR, Berntorp E, Mauser Bunschoten EP, Fijnvandraat K, Kasper CK, White G, Santagostino E. Hay CR, et al. Thromb Haemost. 1998 Apr;79(4):762-6. Thromb Haemost. 1998. PMID: 9569189

2

The incidence of factor VIII inhibitors in the United Kingdom, 1990-93. Inhibitor Working Party. United Kingdom Haemophilia Centre Directors Organization.

Colvin BT, Hay CR, Hill FG, Preston FE. Colvin BT, et al. Among authors: hay cr. Br J Haematol. 1995 Apr;89(4):908-10. doi: 10.1111/j.1365-2141.1995.tb08435.x. Br J Haematol. 1995. PMID: 7772532

3

Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey.

Hay CR, Lozier JN, Lee CA, Laffan M, Tradati F, Santagostino E, Ciavarella N, Schiavoni M, Fukui H, Yoshioka A, Teitel J, Mannucci PM, Kasper CK. Hay CR, et al. Thromb Haemost. 1996 Jan;75(1):25-9. Thromb Haemost. 1996. PMID: 8713775

4

Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party.

Hay CR, Colvin BT, Ludlam CA, Hill FG, Preston FE. Hay CR, et al. Blood Coagul Fibrinolysis. 1996 Mar;7(2):134-8. Blood Coagul Fibrinolysis. 1996. PMID: 8735802

5

HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.

Hay CR, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC, Colvin BT, Hill FG, Preston FE, Peake IR. Hay CR, et al. Thromb Haemost. 1997 Feb;77(2):234-7. Thromb Haemost. 1997. PMID: 9157572

6

The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.

Hay CR, Negrier C, Ludlam CA. Hay CR, et al. Thromb Haemost. 1997 Dec;78(6):1463-7. Thromb Haemost. 1997. PMID: 9423795 Clinical Trial.

7

The factor VIII treatment history of non-severe hemophilia A.

Abdi A, Kloosterman FR, Eckhardt CL, Male C, Castaman G, Fischer K, Beckers EAM, Kruip MJHA, Peerlinck K, Mancuso ME, Santoro C, Hay CR, Platokouki H, van der Bom JG, Gouw SC, Fijnvandraat K, Hart DP; INSIGHT Study Group. Abdi A, et al. Among authors: hay cr. J Thromb Haemost. 2020 Dec;18(12):3203-3210. doi: 10.1111/jth.15076. Epub 2020 Sep 28. J Thromb Haemost. 2020. PMID: 32877570 Free PMC article.

8

European retrospective study of real-life haemophilia treatment.

Berntorp E, Dolan G, Hay C, Linari S, Santagostino E, Tosetto A, Castaman G, Álvarez-Román MT, Parra Lopez R, Oldenburg J, Albert T, Scholz U, Holmström M, Schved JF, Trossaërt M, Hermans C, Boban A, Ludlam C, Lethagen S. Berntorp E, et al. Haemophilia. 2017 Jan;23(1):105-114. doi: 10.1111/hae.13111. Epub 2016 Oct 20. Haemophilia. 2017. PMID: 27761962

9

The effect of monoclonal or ion-exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparison.

Hay CR, Ludlam CA, Lowe GD, Mayne EE, Lee RJ, Prescott RJ, Lee CA. Hay CR, et al. Br J Haematol. 1998 Jun;101(4):632-7. doi: 10.1046/j.1365-2141.1998.00753.x. Br J Haematol. 1998. PMID: 9674733 Free article.

10

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).

Hay CR, Baglin TP, Collins PW, Hill FG, Keeling DM. Hay CR, et al. Br J Haematol. 2000 Oct;111(1):78-90. doi: 10.1046/j.1365-2141.2000.02327.x. Br J Haematol. 2000. PMID: 11091185 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page